Every month, patients from the United States, Canada, Australia, the United Kingdom, the Middle East, and dozens of other countries arrive at our clinic in Bad Aibling. Many have been ill for years. Most have seen multiple physicians in their home countries. Nearly all have been told, at some point, that their suffering is psychosomatic.
They fly to Germany because they have run out of options at home.
This is not a marketing statement. It is a reflection of a structural problem in how chronic Lyme disease is managed in many countries — particularly the United States and the United Kingdom — and why Germany, and Central Europe more broadly, has become a destination for patients seeking comprehensive tick-borne disease care.
The Treatment Gap
In the United States, the management of Lyme disease is largely governed by guidelines from the Infectious Diseases Society of America (IDSA), which recommend short courses of antibiotics and do not recognize chronic Lyme disease as a distinct entity requiring extended treatment. Physicians who treat outside these guidelines face scrutiny from medical boards and insurance companies. The result is a treatment gap: patients who do not respond to standard therapy have few options.
Lyme-literate physicians (LLMDs) exist in the United States and offer more comprehensive treatment, but they often operate in a regulatory gray zone. Insurance coverage for extended Lyme treatment is frequently denied. IV antibiotic therapy, even when medically indicated, can be difficult to arrange and sustain.
In Germany, the medical culture around tick-borne disease is different:
Tick-borne disease is endemic and acknowledged. Germany has among the highest rates of tick-borne disease in Europe. The medical profession has lived with these infections for decades. While guideline debates exist here as well, there is broader clinical recognition that chronic tick-borne disease is a real and treatable condition.
Integrative medicine is part of the healthcare system. Germany has a tradition of Naturheilkunde (naturopathic medicine) integrated within the conventional medical framework. Therapies like hyperthermia, ozone therapy, and IV nutrient support that are considered “alternative” in other countries are part of routine clinical practice in many German hospitals and clinics.
Regulatory environment allows comprehensive care. German physicians have more latitude to design individualized treatment programs that combine conventional antimicrobials with supportive therapies. This is not about practicing outside evidence-based medicine — it is about practicing within a system that defines evidence-based medicine more broadly.
What Our Facility Offers
Our clinic has treated tick-borne disease for over four decades, initially under the direction of my late father, Dr. Friedrich Douwes, and now under my leadership. The approach has evolved considerably, but the core philosophy remains: chronic Lyme disease requires a comprehensive, multimodal program, not a single prescription.
Comprehensive Diagnostics
International patients frequently arrive with incomplete diagnostic workups. The tick that transmits Borrelia often carries multiple pathogens simultaneously. A patient diagnosed with “Lyme disease” may actually have Lyme plus Bartonella, Babesia, Ehrlichia, or Mycoplasma — each requiring different treatment. We test comprehensively, using both conventional serology and advanced diagnostic modalities.
Multimodal Treatment Programs
Our inpatient treatment programs typically span two to four weeks and integrate:
- Targeted antimicrobial therapy — oral and IV antibiotics, selected based on identified pathogens and their susceptibility profiles, including combination protocols addressing different morphological forms
- Whole-body hyperthermia — we have used therapeutic hyperthermia for decades. Many tick-borne pathogens are heat-sensitive, and controlled elevation of body temperature creates an environment hostile to the organisms while stimulating immune function. This is one of the therapies most commonly cited by returning patients as a turning point in their treatment.
- Regional and local hyperthermia for targeted tissue heating
- IV nutrient therapy — high-dose vitamin C, glutathione, B vitamins, minerals, NAD+ — addressing the nutritional depletion and mitochondrial dysfunction that accompany chronic infection
- Ozone therapy — as an antimicrobial adjunct and immune modulator
- Detoxification support — including hepatic support, lymphatic drainage, and management of Herxheimer reactions
- Immunomodulatory therapies — thymus peptides, mistletoe therapy, and other immune-supportive approaches
- Physical therapy and rehabilitation
Integrated Medical Team
Patients are managed by a multidisciplinary team including infectious disease physicians, internists, and nursing staff experienced in complex tick-borne disease. Dr. Angelina Svircev leads much of our Lyme-specific clinical work, supported by Dr. Gabriele Zabel and Dr. Frank Biok in infectiology.
The Practical Considerations
I want to be transparent about the realities of traveling internationally for medical treatment:
Cost. Treatment at our facility is not inexpensive, and most international insurance plans do not cover the full scope of an inpatient program. We provide detailed cost estimates before patients travel and work with international insurance where possible.
Duration. Most international Lyme patients should plan for a minimum two-week program, with some requiring three to four weeks for complex presentations. Post-discharge follow-up can be managed remotely in many cases, with coordination with the patient’s home physician.
Language. Our facility treats patients from over 90 countries. Medical consultations are available in English and German, and interpreter services are available for other languages.
Not every patient responds. I do not want to create the impression that traveling to Germany guarantees recovery. What I can say is that many patients who have not responded to standard therapy in their home countries do respond to a comprehensive, multimodal program. The success rate is meaningful but not universal, and I discuss realistic expectations with every patient before they travel.
Why the Approach Works
The advantage of the German integrative model for chronic Lyme disease is not any single therapy. It is the combination:
- Comprehensive diagnosis identifies all relevant pathogens, not just Borrelia
- Antimicrobial therapy targets multiple morphological forms and co-infections
- Hyperthermia creates conditions that antibiotics alone cannot
- Immune support enhances the patient’s own defenses rather than relying solely on pharmaceuticals
- Detoxification and supportive care manage the significant treatment burden
- Inpatient setting allows daily monitoring and adjustment
This is what I have seen work, repeatedly, in patients who had exhausted their options elsewhere. It is not a miracle. It is methodical, evidence-informed, comprehensive medicine applied with patience and experience.
This content is educational and does not constitute medical advice. International patients considering treatment should contact our clinic directly for a preliminary assessment and detailed information about programs, costs, and logistics.
